SLNO•benzinga•
Soleno Therapeutics Announces Oral Presentation Featuring DCCR Extended-Release Tablets In Prader-Willi Syndrome At ENDO 2024
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 22, 2024 by benzinga